Title: Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
Subjects: Drug approval, Generic drugs, Government policy, Biologicals, Drug accessibility, Administrative Fees, Rules and practice, United States. Food and Drug Administration, United States
Places: United States